Combining CD3 density and PD-L1 expression into one prognostic factor identifies patients with an exceptional prognosis

Introduction T cell infiltrates have previously been associated with a good prognosis. For PD-L1 expression aside of treatment targeting the PD1/PD-L1 axis data are controversial. In this analysis, we combined both markers in a cohort of patients treated with surgery and risk-adapted adjuvant therapy.